Effects of Coenzyme Q10 (CoQ) in Parkinson Disease (QE3)
http://www.clinicaltrials.gov/ct2/sh...Disease&rank=1
This study is currently recruiting participants.
69 Study Sites
Verified by National Institute of Neurological Disorders and Stroke (NINDS), December 2008
Sponsors and Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Weill Medical College of Cornell University
University of Rochester
Information provided by: National Institute of Neurological Disorders and Stroke (NINDS)
ClinicalTrials.gov Identifier]: NCT00740714
Purpose
The purpose of this study is to evaluate the safety and effectiveness of high dosages of Coenzyme Q10 in slowing clinical decline in people who have early Parkinson disease.
Condition: Parkinson Disease
InterventionDrug: Coenzyme Q10 with vitamin E
Drug: placebo with vitamin E
Phase: III